Phase 1 Overweight trials recruiting now

All Overweight trials, every phase

Other phases for Overweight

Phase 1 Overweight trials

• A Clinical Study of Semaglutide Nasal Spray in Overweight or Obese Adults
  NCT07465965 · Phase: Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• A First-in-human Research Study on How NNC0721-8060 Works in People Living With Overweight or Obesity
  NCT07767175 · Phase: Phase 1 · Ages: 18 Years to 55 Years · Sex: All (male and female) · 2 locations
• A Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HRS-5817 Injection
  NCT06934408 · Phase: Phase 1 · Ages: 18 Years to 55 Years · Sex: All (male and female) · 1 location
• A Research Study Investigating How a New Medicine NNC0113-5840 Works in People With Overweight or Obesity
  NCT07566390 · Phase: Phase 1 · Ages: 18 Years to 55 Years · Sex: All (male and female) · 2 locations
• A Research Study Investigating the Effect of NNC0497-0040 in Healthy Participants, Participants With Overweight or Obesity, and Participants With Type 1 Diabetes With Overweight or Obesity
  NCT07578584 · Phase: Phase 1 · Ages: 18 Years to 55 Years · Sex: All (male and female) · 1 location
• A Research Study Looking Into How Cagrilintide Influences Food Intake and Appetite in People With Overweight or Obesity
  NCT07557953 · Phase: Phase 1 · Ages: 18 Years to 64 Years · Sex: All (male and female) · 1 location
• A Research Study Looking Into How NNC0662-0419 Works With Birth Control Pills and Emptying of the Stomach in Women Not Able to Become Pregnant With Excess Body Weight
  NCT07525791 · Phase: Phase 1 · Ages: 18 Years to 64 Years · Sex: Female · 1 location
• A Research Study Looking Into How UBT251 Works With Birth Control Tablets and Emptying of the Stomach in Women With Excess Body Weight Not Able to Become Pregnant
  NCT07710729 · Phase: Phase 1 · Ages: 18 Years to 65 Years · Sex: Female · 1 location
• A Research Study on How UBT251 Affects Levels of Midazolam, Caffeine and Warfarin in the Blood of Participants With Excess Body Weight
  NCT07710768 · Phase: Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• A Research Study to Compare Blood Levels of Cagrilintide After Multiple Doses of Different Versions of Cagrilintide in Adults With Overweight or Obesity
  NCT07597018 · Phase: Phase 1 · Ages: 18 Years to 64 Years · Sex: All (male and female) · 1 location
• A Research Study to See How NNC0487-0111 Affects the Body's Energy Use After a Weight Loss in Adults Living With Obesity, Compared to a Low-calorie Diet or Placebo
  NCT07757087 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• A Study Investigating the Safety of RO7795081 and the Effect of RO7795081 on How the Body Processes Pitavastatin and Rosuvastatin in Otherwise Healthy Overweight or Obese Adult Participants
  NCT06982131 · Phase: Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• A Study Looking at How Weekly Injections of Two Hormones - GIP and Amylin - Affect Stomach-related Side Effects in People Who Are Overweight or Obese
  NCT07411560 · Phase: Phase 1 · Ages: 18 Years to 64 Years · Sex: Female · 1 location
• A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight
  NCT07738614 · Phase: Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 2 locations
• A Study of Eloralintide (LY3841136) in Participants With Overweight or Obesity
  NCT07665879 · Phase: Phase 1 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 2 locations
• A Study of LY4174794 in Participants With Obesity or Overweight Who Are Otherwise Healthy
  NCT07654972 · Phase: Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 3 locations
• A Study of SHR-2906 Injection in Healthy Subjects With a Single Dose and in Obese Patients With Multiple Doses
  NCT07280936 · Phase: Phase 1 · Ages: 18 Years to 55 Years · Sex: All (male and female) · 1 location
• A Study to Learn How the Study Medicine Called PF-08653945 is Taken up Into the Blood in Adults With Overweight or Obesity
  NCT07725809 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• A Study to See How Safe a New Medicine (NNC6989-0001) is in Healthy People Living With Overweight or Obesity
  NCT07437079 · Phase: Phase 1 · Ages: 18 Years to 55 Years · Sex: All (male and female) · 1 location
• A Trial of Oral VRB-103 Alone or in Combination With Oral Ecnoglutide (VRB-101) in Participants With Obesity or Overweight
  NCT07628127 · Phase: Phase 1 · Ages: 18 Years to 60 Years · Sex: All (male and female) · 1 location
• Evaluation of the Tolerability of Cagrilintide in Participants Not Tolerating GLP-1-RA Therapies Due to Gastrointestinal Adverse Events
  NCT07607587 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 11 locations
• IBI3042 Study in Healthy Participants and Overweight or Obese Participants
  NCT07793019 · Phase: Phase 1 · Ages: 18 Years to 55 Years · Sex: All (male and female) · 1 location

Common questions

What does Phase 1 mean?

See how clinical trials work.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.